This document provides the strategic aims and proposed actions of the CVMP for the period 2021-2025 in relation to antimicrobials. It also provides a status report on ongoing activities on antimicrobials.
Keywords: Antimicrobial resistance, CVMP, strategy
Current effective version
CVMP strategy on antimicrobials 2021-2025
English (EN) (302.83 KB - PDF)
Document history
Overview of comments received on 'CVMP strategy on antimicrobials 2021-2025'
English (EN) (321.15 KB - PDF)
Draft CVMP strategy on antimicrobials 2021-2025
The CVMP’s draft strategy on antimicrobials for the period from 2021 to 2025 is now published for public consultation until 30 September 2020. The focus of the CVMP’s activities will be on supporting the effective implementation of those provisions in the Regulation (EU) 2019/6 that take forward the EU’s One Health Action Plan against antimicrobial resistance (AMR).
English (EN) (325.1 KB - PDF)
CVMP strategy on antimicrobials 2016-2020
The Committee adopted the revised CVMP strategy on antimicrobials for the period 2016-2020. The CVMP vision on antimicrobials aims to ensure the availability of effective antimicrobial medicines for the treatment of infectious diseases of animals while, at the same time, minimising the risks to animals or humans arising from their use. The strategy intends to strengthen the benefit-risk assessment for antimicrobial veterinary medicinal products in a One Health context.
English (EN) (189.97 KB - PDF)
Overview of comments received on 'CVMP strategy on antimicrobials 2016-2020' (EMA/CVMP/209189/2015)
Following the end of the consultation period of the CVMP strategy on Antimicrobials 2016-2020 the Committee revised the comments received from nine stakeholders. The overview of comments document contains the answers provided by the Committee.
English (EN) (541.09 KB - PDF)
Draft CVMP strategy on antimicrobials 2016-2020
The draft Committee for Medicinal Products for Veterinary Use (CVMP) strategy on antimicrobials for 2016-2020 sets clear objectives and course of action for the next five years, based on a 'One Health' approach. The CVMP’s vision is the availability of effective antimicrobial medicines for the treatment of important infectious diseases of animals with, at the same time, minimum risks to animals or humans arising from their use.
English (EN) (169.2 KB - PDF)
Related content
CVMP strategy on antimicrobials 2011-2015
English (EN) (132.75 KB - PDF)
Overview of comments received on the Committee for Medicinal Products for Veterinary Use strategy on antimicrobials 2011-2015
English (EN) (282.45 KB - PDF)
CVMP draft strategy on antimicrobials 2011-2015
English (EN) (134.53 KB - PDF)
Committee on Medicinal Products for Veterinary Use strategy on antimicrobials 2006-2010 and status report on activities on antimicrobials
English (EN) (114.48 KB - PDF)